5J6 Stock Overview
Designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
OssDsign AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 0.55 |
52 Week High | SEK 0.91 |
52 Week Low | SEK 0.43 |
Beta | 0.82 |
11 Month Change | -11.76% |
3 Month Change | -29.11% |
1 Year Change | 7.45% |
33 Year Change | -32.93% |
5 Year Change | n/a |
Change since IPO | -62.34% |
Recent News & Updates
Recent updates
Shareholder Returns
5J6 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | -7.6% | 3.6% | 1.5% |
1Y | 7.5% | 3.6% | 12.6% |
Return vs Industry: 5J6 exceeded the German Medical Equipment industry which returned 4.8% over the past year.
Return vs Market: 5J6 underperformed the German Market which returned 11.2% over the past year.
Price Volatility
5J6 volatility | |
---|---|
5J6 Average Weekly Movement | 6.8% |
Medical Equipment Industry Average Movement | 5.0% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 11.7% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 5J6's share price has been volatile over the past 3 months.
Volatility Over Time: 5J6's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | 27 | Morten Henneveld | www.ossdsign.com |
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. It offers OssDsign Catalyst, a nanosynthetic bone graft used to help stimulate bone growth in spinal fusions. The company was founded in 2011 and is headquartered in Uppsala, Sweden.
OssDsign AB (publ) Fundamentals Summary
5J6 fundamental statistics | |
---|---|
Market cap | €57.89m |
Earnings (TTM) | -€10.07m |
Revenue (TTM) | €10.92m |
5.3x
P/S Ratio-5.7x
P/E RatioIs 5J6 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
5J6 income statement (TTM) | |
---|---|
Revenue | SEK 123.46m |
Cost of Revenue | SEK 19.83m |
Gross Profit | SEK 103.63m |
Other Expenses | SEK 217.44m |
Earnings | -SEK 113.80m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 05, 2024
Earnings per share (EPS) | -1.17 |
Gross Margin | 83.94% |
Net Profit Margin | -92.18% |
Debt/Equity Ratio | 0.2% |
How did 5J6 perform over the long term?
See historical performance and comparison